Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SHAAN MOHAMMED RAZA and FRANCO DEMONTE.
SHAAN MOHAMMED RAZA
Connection Strength
11.893
FRANCO DEMONTE
  1. Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse. Neurosurgery. 2020 01 01; 86(1):E23-E32.
    View in: PubMed
    Score: 0.707
  2. Olfactory groove and planum meningiomas. Handb Clin Neurol. 2020; 170:3-12.
    View in: PubMed
    Score: 0.707
  3. Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival. Oper Neurosurg (Hagerstown). 2018 08 01; 15(2):131-143.
    View in: PubMed
    Score: 0.641
  4. Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown). 2018 06 01; 14(6):611-619.
    View in: PubMed
    Score: 0.633
  5. Multimodality Treatment of Skull Base Chondrosarcomas: The Role of Histology Specific Treatment Protocols. Neurosurgery. 2017 Sep 01; 81(3):520-530.
    View in: PubMed
    Score: 0.601
  6. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
    View in: PubMed
    Score: 0.511
  7. Retrosigmoid craniotomy for cerebellopontine angle/petroclival epidermoid cyst. Neurosurg Focus. 2014 Jan; 36(1 Suppl):1.
    View in: PubMed
    Score: 0.466
  8. Impact of Previous Surgery and/or Radiation Therapy on Endoscopic Reconstruction Outcomes. Oper Neurosurg (Hagerstown). 2024 Aug 26.
    View in: PubMed
    Score: 0.244
  9. Surgical Management of High-Grade Meningiomas. Cancers (Basel). 2024 May 23; 16(11).
    View in: PubMed
    Score: 0.240
  10. Induction Chemotherapy for Sinonasal Tumors in Patients Presenting with Brain Invasion and/or Neurological Deficits. J Neurol Surg B Skull Base. 2024 Dec; 85(6):650-658.
    View in: PubMed
    Score: 0.229
  11. Long-term oncological outcomes for endoscopic endonasal versus open surgical approaches for anatomically matched, locally advanced stage T4 sinonasal malignancies with skull base involvement. J Neurosurg. 2024 Mar 01; 140(3):688-695.
    View in: PubMed
    Score: 0.229
  12. Does Time to Initiation of Adjuvant Radiotherapy Affect Reconstruction Outcomes after Endoscopic Resection of Skull Base Malignancies? J Neurol Surg B Skull Base. 2024 Oct; 85(5):445-457.
    View in: PubMed
    Score: 0.226
  13. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies. Neurosurg Rev. 2023 Jun 29; 46(1):157.
    View in: PubMed
    Score: 0.225
  14. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy. J Neurosurg. 2023 09 01; 139(3):798-809.
    View in: PubMed
    Score: 0.219
  15. Volumetric extent of resection and survival for recurrent atypical meningioma. J Neurosurg. 2023 09 01; 139(3):769-779.
    View in: PubMed
    Score: 0.219
  16. Patient, Disease, and Treatment-Related Factors Affecting Progression-Free and Disease-Specific Survival in Recurrent Chondrosarcomas of the Skull Base. Oper Neurosurg (Hagerstown). 2023 01 01; 24(1):33-43.
    View in: PubMed
    Score: 0.215
  17. Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. J Exp Clin Cancer Res. 2022 Oct 04; 41(1):292.
    View in: PubMed
    Score: 0.214
  18. Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels. Front Oncol. 2022; 12:997506.
    View in: PubMed
    Score: 0.214
  19. Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
    View in: PubMed
    Score: 0.213
  20. The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies:a case series. J Neurooncol. 2022 Sep; 159(3):627-635.
    View in: PubMed
    Score: 0.212
  21. Impact of Radiation Therapy on Outcomes After Spinal Instrumentation for Craniocervical Junction Malignancies. Neurospine. 2022 Jun; 19(2):434-440.
    View in: PubMed
    Score: 0.208
  22. Impact of salvage surgery for recurrent sinonasal cancers with skull base and intracranial involvement. J Neurosurg. 2022 Oct 01; 137(4):961-968.
    View in: PubMed
    Score: 0.204
  23. The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center. J Neurosurg. 2022 Jun 01; 136(6):1583-1591.
    View in: PubMed
    Score: 0.200
  24. Outcomes of orbital exenteration for craniofacial lesions. Cancer. 2021 07 15; 127(14):2465-2475.
    View in: PubMed
    Score: 0.193
  25. Surgical Management of Skull Base and Spine Chordomas. Curr Treat Options Oncol. 2021 03 20; 22(5):40.
    View in: PubMed
    Score: 0.192
  26. Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma. Neurosurgery. 2021 01 13; 88(2):428-436.
    View in: PubMed
    Score: 0.190
  27. Surgical Management of Skull Base Osteoradionecrosis in the Cancer Population - Treatment Outcomes and Predictors of Recurrence: A Case Series. Oper Neurosurg (Hagerstown). 2020 09 15; 19(4):364-374.
    View in: PubMed
    Score: 0.186
  28. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2021 05 01; 134(5):1392-1398.
    View in: PubMed
    Score: 0.182
  29. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase. J Neurooncol. 2020 Dec; 150(3):367-375.
    View in: PubMed
    Score: 0.181
  30. Advances in the management of primary bone sarcomas of the skull base. J Neurooncol. 2020 Dec; 150(3):393-403.
    View in: PubMed
    Score: 0.180
  31. Management of Recurrent or Progressing Skull Base Chondrosarcomas: Predictors of Long-Term Outcomes. J Neurol Surg B Skull Base. 2021 Jul; 82(Suppl 3):e155-e165.
    View in: PubMed
    Score: 0.178
  32. Salvage Therapy for Local Progression following Definitive Therapy for Skull Base Chordomas: Is There a Role of Stereotactic Radiosurgery? J Neurol Surg B Skull Base. 2020 Feb; 81(1):97-106.
    View in: PubMed
    Score: 0.167
  33. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression. Oper Neurosurg (Hagerstown). 2019 01 01; 16(1):27-36.
    View in: PubMed
    Score: 0.165
  34. Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. J Neurosurg. 2019 07 01; 131(1):184-191.
    View in: PubMed
    Score: 0.160
  35. Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. J Neurosurg. 2019 03 01; 130(3):812-821.
    View in: PubMed
    Score: 0.157
  36. Endoscopic endonasal resection of sinonasal/anterior skull base malignancy (Kadish C esthesioneuroblastoma). Acta Neurochir (Wien). 2018 Feb; 160(2):361-366.
    View in: PubMed
    Score: 0.154
  37. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien). 2018 04; 160(4):731-740.
    View in: PubMed
    Score: 0.154
  38. Surgical Resection of an Optic Nerve Sheath Meningioma: Relevance of Endoscopic Endonasal Approaches to the Optic Canal. J Neurol Surg Rep. 2017 Apr; 78(2):e81-e85.
    View in: PubMed
    Score: 0.146
  39. Whole-transcriptome analysis of chordoma of the skull base. Virchows Arch. 2016 Oct; 469(4):439-49.
    View in: PubMed
    Score: 0.139
  40. Management of Skull Base Tumor-Associated Facial Pain. Neurosurg Clin N Am. 2016 Jul; 27(3):337-44.
    View in: PubMed
    Score: 0.139
  41. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg. 2016 Jan; 124(1):115-21.
    View in: PubMed
    Score: 0.130
  42. Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clin Cancer Res. 2024 Nov 12.
    View in: PubMed
    Score: 0.062
  43. A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastoma. Head Neck. 2025 Jan; 47(1):81-89.
    View in: PubMed
    Score: 0.061
  44. Skull base surgery for malignant tumors: The 2nd international collaborative study (1995-2015). Head Neck. 2024 Nov; 46(11):2762-2775.
    View in: PubMed
    Score: 0.060
  45. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol. Neurosurg Focus. 2024 05; 56(5):E15.
    View in: PubMed
    Score: 0.060
  46. Subependymomas of the fourth ventricle: To operate or not to operate? J Clin Neurosci. 2023 Dec; 118:147-152.
    View in: PubMed
    Score: 0.058
  47. Sinonasal NUT carcinoma: A consecutive case series and systematic review. Head Neck. 2024 01; 46(1):29-36.
    View in: PubMed
    Score: 0.057
  48. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head Neck. 2023 10; 45(10):2525-2532.
    View in: PubMed
    Score: 0.057
  49. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma. Otolaryngol Head Neck Surg. 2023 08; 169(2):435-440.
    View in: PubMed
    Score: 0.055
  50. The Effect of Metformin on Vestibular Schwannoma Growth: A Systematic Review and Meta-analysis. Laryngoscope. 2023 09; 133(9):2066-2072.
    View in: PubMed
    Score: 0.055
  51. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope. 2022 02; 132(2):290-297.
    View in: PubMed
    Score: 0.049
  52. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer. 2021 06 01; 127(11):1788-1795.
    View in: PubMed
    Score: 0.048
  53. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 05; 131(5):E1468-E1475.
    View in: PubMed
    Score: 0.046
  54. Endoscopic resection of sinonasal malignancies. Head Neck. 2020 04; 42(4):645-652.
    View in: PubMed
    Score: 0.044
  55. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512.
    View in: PubMed
    Score: 0.041
  56. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
    View in: PubMed
    Score: 0.041
  57. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma. Ann Surg Oncol. 2018 Jun; 25(6):1723-1729.
    View in: PubMed
    Score: 0.039
  58. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280.
    View in: PubMed
    Score: 0.038
  59. Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. Cancer. 2018 02 01; 124(3):514-520.
    View in: PubMed
    Score: 0.038
  60. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas. Virchows Arch. 2018 Mar; 472(3):489-497.
    View in: PubMed
    Score: 0.038
  61. Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma. J Neurol Surg B Skull Base. 2017 Dec; 78(6):512-518.
    View in: PubMed
    Score: 0.037
  62. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1040-1048.
    View in: PubMed
    Score: 0.037
  63. Mutation status among patients with sinonasal mucosal melanoma and its impact on survival. Br J Cancer. 2017 Jun 06; 116(12):1564-1571.
    View in: PubMed
    Score: 0.037
  64. Petroclival Chondrosarcoma: A Multicenter Review of 55 Cases and New Staging System. Otol Neurotol. 2016 08; 37(7):940-50.
    View in: PubMed
    Score: 0.035
  65. Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014 Feb; 16(2):369.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.